Age-associated changes of appetite-regulating peptides.
Aging is associated with a progressive decrease in appetite and food intake. The reasons for the decline in food intake are multifactorial, and relate to both peripheral and central mechanisms. Current studies about the regulation of food intake suggest that there are many central mediators that control the appetite. To determine the mechanism of age-associated decrease in appetite and food intake, we focused on the age-associated changes of the suppressing and stimulatory effect of some appetite-regulating peptides. At first, we examined cholecystokinin (CCK), one of the typical appetite-suppressing factors. Although sensitivity to CCK is enhanced in old animals, the mechanism underlying this effect has not been elucidated. Next, we focused on the appetite-stimulating peptides, orexin-A, neuropeptide Y (NPY) and ghrelin, which are known to play a critical role in food intake. To determine the age-associated decrease in appetite and food intake, we compared the stimulatory effect of intracerebroventricular administration of orexin-A, NPY and ghrelin. We report the studies of the age-associated changes of appetite-regulating peptides in this review.
Akimoto
Saeko
S
Tokyo Metropolitan Institute of Gerontology, Tokyo Kasei University, Itabashiku, Tokyo, Japan.
Miyasaka
Kyoko
K
D000375:Aging / Q000502:physiology*; D000818:Animals; D001066:Appetite / Q000187:drug effects* / Q000502:physiology*; D015153:Blotting, Western; D002766:Cholecystokinin / Q000502:physiology*; D004435:Eating / Q000187:drug effects / Q000502:physiology; D054439:Ghrelin / Q000008:administration & dosage / Q000502:physiology; D007031:Hypothalamus / Q000378:metabolism; D047908:Intracellular Signaling Peptides and Proteins / Q000008:administration & dosage / Q000502:physiology*; D009478:Neuropeptide Y / Q000008:administration & dosage / Q000502:physiology*; D009479:Neuropeptides / Q000008:administration & dosage / Q000502:physiology*; D000068797:Orexins; D051381:Rats; D017208:Rats, Wistar; D013566:Sympathomimetics / Q000008:administration & dosage
D054439:Ghrelin; D047908:Intracellular Signaling Peptides and Proteins; D009478:Neuropeptide Y; D009479:Neuropeptides; D000068797:Orexins; D013566:Sympathomimetics; D002766:Cholecystokinin